Search

Leszek B Kiliman

Examiner (ID: 1930, Phone: (571)272-1509 , Office: P/1788 )

Most Active Art Unit
1773
Art Unit(s)
1788, 1787, 1509, 1316, 1773, 1794
Total Applications
2689
Issued Applications
2219
Pending Applications
93
Abandoned Applications
377

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6055800 [patent_doc_number] => 20110112160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'TABLET COMPRISING EPROSARTAN MESYLATE' [patent_app_type] => utility [patent_app_number] => 12/937135 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11255 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112160.pdf [firstpage_image] =>[orig_patent_app_number] => 12937135 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/937135
TABLET COMPRISING EPROSARTAN MESYLATE Apr 7, 2009 Abandoned
Array ( [id] => 7742119 [patent_doc_number] => 20120020901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'ORAL CARE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/262353 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3571 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020901.pdf [firstpage_image] =>[orig_patent_app_number] => 13262353 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/262353
ORAL CARE COMPOSITIONS Apr 1, 2009 Abandoned
Array ( [id] => 6551433 [patent_doc_number] => 20100233231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/401228 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12060 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233231.pdf [firstpage_image] =>[orig_patent_app_number] => 12401228 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/401228
USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION Mar 9, 2009 Abandoned
Array ( [id] => 6102656 [patent_doc_number] => 20110166149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'PTERIDINE DERIVATIVES FOR TREATING RESPIRATORY DISEASE' [patent_app_type] => utility [patent_app_number] => 12/866665 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5715 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166149.pdf [firstpage_image] =>[orig_patent_app_number] => 12866665 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/866665
PTERIDINE DERIVATIVES FOR TREATING RESPIRATORY DISEASE Feb 5, 2009 Abandoned
Array ( [id] => 5986821 [patent_doc_number] => 20110098267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS' [patent_app_type] => utility [patent_app_number] => 12/866735 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41916 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098267.pdf [firstpage_image] =>[orig_patent_app_number] => 12866735 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/866735
TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS Feb 5, 2009 Abandoned
Array ( [id] => 6214391 [patent_doc_number] => 20110136877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => '2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/811823 [patent_app_country] => US [patent_app_date] => 2009-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14434 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136877.pdf [firstpage_image] =>[orig_patent_app_number] => 12811823 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/811823
2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS Jan 5, 2009 Abandoned
Array ( [id] => 6014978 [patent_doc_number] => 20110223226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'SHELF STABLE CAPSULES' [patent_app_type] => utility [patent_app_number] => 13/128243 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4589 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223226.pdf [firstpage_image] =>[orig_patent_app_number] => 13128243 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/128243
Shelf stable capsules Nov 9, 2008 Issued
Array ( [id] => 5944829 [patent_doc_number] => 20110105449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATES' [patent_app_type] => utility [patent_app_number] => 12/740921 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6378 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105449.pdf [firstpage_image] =>[orig_patent_app_number] => 12740921 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/740921
DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATES Nov 5, 2008 Abandoned
Array ( [id] => 10018491 [patent_doc_number] => 09060960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Treatment of dissection, aneurysm, and atherosclerosis using granzyme B inhibitors' [patent_app_type] => utility [patent_app_number] => 12/681293 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17339 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681293 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/681293
Treatment of dissection, aneurysm, and atherosclerosis using granzyme B inhibitors Sep 30, 2008 Issued
Array ( [id] => 10031370 [patent_doc_number] => 09072670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Matrix-type pharmaceutical solid preparation' [patent_app_type] => utility [patent_app_number] => 12/738543 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 19453 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12738543 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738543
Matrix-type pharmaceutical solid preparation Sep 25, 2008 Issued
Array ( [id] => 10082489 [patent_doc_number] => 09119819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Oral liquid compositions of rhein or diacerein' [patent_app_type] => utility [patent_app_number] => 12/989966 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3415 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989966 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989966
Oral liquid compositions of rhein or diacerein Sep 22, 2008 Issued
Array ( [id] => 8896247 [patent_doc_number] => 08475768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (MRI)' [patent_app_type] => utility [patent_app_number] => 12/672113 [patent_app_country] => US [patent_app_date] => 2008-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16736 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12672113 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/672113
Paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (MRI) Aug 11, 2008 Issued
Array ( [id] => 6283965 [patent_doc_number] => 20100236550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'DRY-POWDER MEDICAMENT' [patent_app_type] => utility [patent_app_number] => 12/669523 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5500 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20100236550.pdf [firstpage_image] =>[orig_patent_app_number] => 12669523 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/669523
DRY-POWDER MEDICAMENT Jul 17, 2008 Abandoned
Array ( [id] => 6603162 [patent_doc_number] => 20100323025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'TIMED-RELEASE PHARMACEUTICAL PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/866634 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10213 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323025.pdf [firstpage_image] =>[orig_patent_app_number] => 12866634 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/866634
TIMED-RELEASE PHARMACEUTICAL PREPARATION Jun 29, 2008 Abandoned
Array ( [id] => 6163532 [patent_doc_number] => 20110160302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'DEVICE AND METHODS FOR TREATMENT AND PREVENTION OF TENDON INJURIES' [patent_app_type] => utility [patent_app_number] => 12/452195 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5046 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160302.pdf [firstpage_image] =>[orig_patent_app_number] => 12452195 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/452195
DEVICE AND METHODS FOR TREATMENT AND PREVENTION OF TENDON INJURIES Jun 15, 2008 Abandoned
Array ( [id] => 9983613 [patent_doc_number] => 09029322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Compounds for enhancing p21 expression and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/663091 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 6386 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12663091 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/663091
Compounds for enhancing p21 expression and methods of use thereof Jun 4, 2008 Issued
Array ( [id] => 11217663 [patent_doc_number] => 09445982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Polymer-based pigment-bearing ink' [patent_app_type] => utility [patent_app_number] => 12/124194 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4294 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12124194 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/124194
Polymer-based pigment-bearing ink May 20, 2008 Issued
Array ( [id] => 4726646 [patent_doc_number] => 20080206187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'METHOD FOR TREATING A NEOPLASTIC DISORDER' [patent_app_type] => utility [patent_app_number] => 11/947375 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12128 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206187.pdf [firstpage_image] =>[orig_patent_app_number] => 11947375 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/947375
Method for treating a neoplastic disorder Nov 28, 2007 Issued
Array ( [id] => 5278046 [patent_doc_number] => 20090130178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'FORMULATION FOR DECREASING TOBACCO, ALCOHOL, DRUG OR FOOD CONSUMPTION' [patent_app_type] => utility [patent_app_number] => 11/942414 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4091 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130178.pdf [firstpage_image] =>[orig_patent_app_number] => 11942414 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/942414
Formulation for decreasing tobacco, alcohol, drug or food consumption Nov 18, 2007 Issued
Array ( [id] => 6629525 [patent_doc_number] => 20100311655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'INTRANASAL CARBETOCIN FORMULATIONS AND METHODS FOR THE TREATMENT OF AUTISM' [patent_app_type] => utility [patent_app_number] => 12/599267 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32793 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311655.pdf [firstpage_image] =>[orig_patent_app_number] => 12599267 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/599267
INTRANASAL CARBETOCIN FORMULATIONS AND METHODS FOR THE TREATMENT OF AUTISM Sep 27, 2007 Abandoned
Menu